TRXB — TRex Bio Cashflow Statement
0.000.00%
Last trade - 00:00- $371.07m
- $240.62m
Annual cashflow statement for TRex Bio, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2024 December 31st | 2025 December 31st | |
|---|---|---|
| Period Length: | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS |
| Standards: | USG | USG |
| Status: | Final | Final |
| Net Income/Starting Line | -3.14 | -34.8 |
| Depreciation | ||
| Non-Cash Items | 0.923 | 0.007 |
| Other Non-Cash Items | ||
| Changes in Working Capital | -24.6 | -6.78 |
| Change in Prepaid Expenses | ||
| Change in Other Assets | ||
| Change in Accounts Payable | ||
| Change in Accrued Expenses | ||
| Change in Taxes Payable | ||
| Change in Other Liabilities | ||
| Cash from Operating Activities | -25.6 | -41.4 |
| Capital Expenditures | -0.068 | -0.068 |
| Purchase of Fixed Assets | ||
| Other Investing Cash Flow Items | -17.2 | -32.9 |
| Sale/Maturity of Investment | ||
| Purchase of Investments | ||
| Cash from Investing Activities | -17.3 | -33 |
| Financing Cash Flow Items | -0.474 | -0.01 |
| Other Financing Cash Flow | ||
| Net Issuance / Retirement of Stock | ||
| Cash from Financing Activities | 41.9 | 42.1 |
| Beginning Cash Balance | ||
| Ending Cash Balance | ||
| Net Change in Cash | -1.03 | -32.3 |